‘The International Society for Immunohistochemistry and Molecular Morphology’ (ISIMM) was founded in March, 2016, during the week of the USCAP meeting in Seattle, USA. The major driving ‘force’ for this effort has been an initiative of the external quality control and assurance agencies, NordiQC, CIQC, UKNEQAS, IQNPath (and others), and editorial board members of AIMM, which is the affiliated journal of the new society. As part of the foundation process the existing Society for Applied Immunohistochemistry has agreed to merge its activities and its members into ISIMM.
The mission of ISIMM is to promote knowledge, innovation and excellence in slide-based techniques such as immunohistochemistry and in situ hybridization. The Society seeks to increase knowledge of methods, applications, and limitations of these slide based techniques, and to provide leadership and education in the form of seminars, publications, and best practice guidelines with the overarching goal of improving patient care.